China Resources Boya Bio-pharmaceutical Group Co., Ltd.

China Resources Boya Bio-pharmaceutical Group Co., Ltd.verified

300294.SZ

Price:

$23.17

Market Cap:

$11.68B

China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, diabetes medication, biochemical medication, and chemical medicine businesses in China. It engages in the research and development, production, and sales of blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, human albumin, human immunoglobulin, freeze-dried intravenous human immunoglobulin, and hepatitis B human immunoglobulin; diabetes products, including metformin hydrochloride tablets/enteric-coated tablets, pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules; and compound osteotide, oxytocin, and heparin ...[Read more]

Industry

Biotechnology

IPO Date

2012-03-08

Stock Exchange

SHZ

Ticker

300294.SZ

The PE Ratio as of December 2025 (TTM) for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) is 35.65

According to China Resources Boya Bio-pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 35.65. This represents a change of -192.38% compared to the average of -38.59 of the last 4 quarters.

China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) Historical PE Ratio (quarterly & annually)

How has 300294.SZ PE Ratio performed in the past?

The mean historical PE Ratio of China Resources Boya Bio-pharmaceutical Group Co., Ltd. over the last ten years is 44.02. The current 35.65 PE Ratio has changed 8.00% with respect to the historical average. Over the past ten years (40 quarters), 300294.SZ's PE Ratio was at its highest in in the December 2022 quarter at 331.13. The PE Ratio was at its lowest in in the December 2024 quarter at -242.95.

Quarterly (TTM)
Annual

Average

44.02

Median

40.56

Minimum

22.83

Maximum

70.60

China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of China Resources Boya Bio-pharmaceutical Group Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 75.90%

Maximum Annual PE Ratio = 70.60

Minimum Annual Increase = -45.52%

Minimum Annual PE Ratio = 22.83

Quarterly (TTM)
Annual
YearPE RatioChange
202438.46-45.52%
202370.6065.50%
202242.65-12.13%
202148.54-11.63%
202054.9375.90%
201931.2336.80%
201822.83-35.40%
201735.34-4.06%
201636.83-37.34%
201558.7835.44%

China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) Average PE Ratio

How has 300294.SZ PE Ratio performed in the past?

The current PE Ratio of China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

50.57

5-year avg

51.04

10-year avg

44.02

China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) PE Ratio vs. Peers

How is 300294.SZ’s PE Ratio compared to its peers?

China Resources Boya Bio-pharmaceutical Group Co., Ltd.’s PE Ratio is greater than Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (24.76), less than Hualan Biological Bacterin Inc. (163.22), greater than Zhejiang Jolly Pharmaceutical Co.,LTD (19.67), greater than Tibet Cheezheng Tibetan Medicine Co., Ltd. (22.30), greater than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (8.90), greater than Shanghai Haohai Biological Technology Co., Ltd. (26.62), less than Jinyu Bio-technology Co., Ltd. (159.74), less than Chengdu Easton Biopharmaceuticals Co., Ltd. (41.38), less than Sansure Biotech Inc. (40.56), less than Chengdu Kanghua Biological Products Co., Ltd. (53.30),

Build a custom stock screener for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Resources Boya Bio-pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China Resources Boya Bio-pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is China Resources Boya Bio-pharmaceutical Group Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?

What is the highest PE Ratio for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?

What is the 3-year average PE Ratio for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?

What is the 5-year average PE Ratio for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?

How does the current PE Ratio for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) compare to its historical average?